Immediate Impact

8 by Nobel laureates 3 from Science/Nature 66 standout
Sub-graph 1 of 23

Citing Papers

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
2023 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
2 intermediate papers

Works of D Abigerges being referenced

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
1995
Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials
1995
and 1 more

Author Peers

Author Last Decade Papers Cites
D Abigerges 662 605 40 115 12 817
Daniel Gandía 492 426 33 128 12 659
R J van Alphen 532 548 23 101 6 853
E Gupta 652 768 42 75 15 988
Rebecca R. Thomas 549 251 45 109 10 881
E. Boven 495 302 28 113 25 758
Timothy M. Lestingi 554 594 27 178 26 836
Ayako Yukita 210 539 25 78 12 719
Paola Biason 543 501 21 158 20 886
Maura A. Kraynak 423 305 27 149 19 790
Stella Chai 362 603 8 61 20 941

All Works

Loading papers...

Rankless by CCL
2026